Apr 11 |
Nautilus Biotechnology to Announce First Quarter 2024 Financial Results on April 30, 2024
|
Mar 11 |
This Nautilus Biotechnology Insider Increased Their Holding In The Last Year
|
Feb 28 |
Nautilus Biotechnology files $300M mixed securities shelf
|
Feb 28 |
Nautilus Biotechnology, Inc. (NAUT) Q4 2023 Earnings Call Transcript
|
Feb 28 |
Nautilus Biotechnology GAAP EPS of -$0.14 beats by $0.01
|
Feb 28 |
Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2023 Financial Results
|
Feb 28 |
Nautilus Biotechnology Inc (NAUT) Reports Fiscal Year 2023 Financial Results
|
Feb 7 |
Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024
|
Nov 1 |
Nautilus Biotechnology Appoints Martin Huber, Ph.D., as Vice President of Biochemistry and Flow Cell Development
|
Oct 31 |
Nautilus Biotechnology, Inc. (NAUT) Q3 2023 Earnings Call Transcript
|